Quality key factors
Factor
Value
Sales Growth (5y)
-31.57%
EBIT Growth (5y)
-229.91%
EBIT to Interest (avg)
-3.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.65
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.96%
ROE (avg)
0.52%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.86
EV to EBIT
-7.58
EV to EBITDA
-7.58
EV to Capital Employed
3.97
EV to Sales
5.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.44%
ROE (Latest)
-27.48%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Biohit Oyj
Net Sales - Half-Yearly
At EUR 7 MM has Grown at 37.50 %
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (EUR MM)
Net Sales - Half-Yearly
Highest at EUR 7 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Cash and Cash Equivalents - Half Yearly
Highest at EUR 3.03 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents (EUR MM)






